Posted on August 1, 2011 by Sitemaster
A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, color Döppler, Diagnosis, guidance, SonoVue, transrectal, ultrasound | 4 Comments »
Posted on July 9, 2010 by Sitemaster
Here in the USA there has been a nucleus of physicians who have argued for years that the use of color Doppler ultrasound enhances the ability to identify and biopsy prostate cancer. New data from Germany are relevant to this conversation. … READ MORE …
Filed under: Diagnosis, Management | Tagged: biopsy, color Döppler, systematic, ultrasound | 7 Comments »
Posted on November 25, 2009 by Sitemaster
There have been a number of interesting reports over the past couple of days that are summarized briefly below. They encompass such topics as:
- The validity of the Epstein criteria in predicting clinically indolent prostate cancer
- MRI and MRSI in patient work-up prior to treatment for stage T1c disease
- Contrast-enhanced, color Döppler ultrasound and prostate biopsy
- Gleason scores and cancer “laterality” on biopsy and after surgery
- Accuracy of prediction of “unilateral” prostate cancer, and implications for focal surgery
- Patient age and probability of indolent disease
- Testosterone levels, comorbidities, ADT, and mortality
- A new “prostate mechanical imaging system” … READ MORE …
Filed under: Uncategorized | Tagged: ADT, age, androgen deprivation therapy, color Döppler, comorbidities, Epsetin criteria, Gleason score, magnetic resonance, mortality, MRI, MRSI, testosterone, ultrasound, unilateral | 2 Comments »